Abstract
Venom from the tropical ant,Pseudomyrmex. triplarinus, has activity against rheumatoid arthritis. Since platelets are involved in inflammatory responses, they were employed to study the effects of venom on prostaglandin-dependent human platelet aggregation and secretion. The assay is very sensitive and uses microliter volumes, which makes it useful as a screen during isolation and characterization of venom components. Whole venom inhibited arachidonic acid- and U46619-induced platelet aggregation with IC50s of 45 and 39 μg/ml, respectively. This suggested that venom prevented the action of prostaglandins. Pure venom was fractionated by gel filtration and at least three materials with antiplatelet activity were detected. The smallest component (factor F) was most active and was purified by additional molecular filtration and characterized by UV absorbance, thin-layer chromatography, nuclear magnetic resonance spectra, and activity to platelets. Factor F was identified as adenosine, which is known to stimulate platelet adenylate cyclase and has not been previously reported to be a component of insect venom.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Altman, R. D., D. R. Schultz, B. Collins-Yudiskas, J. Aldrich, P. I. Arnold, andH. E. Brown. 1984. The effects of a partially purified fraction of an ant venom in rheumatoid arthritis.Arthritis Rheum. 27:277–284.
Winter, C. A., E. A. Risley, andG. W. Nuss. 1962. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs.Proc. Soc. Exp. Biol. Med. 111:544–547.
Hink, W. F., andJ. J. Butz. 1985. Primary culture of ant venom gland cells.In Vitro Cell. Dev. Biol. 21:333–339.
Schultz, D. R., andP. I. Arnold. 1984. Invmunochemical and clinical studies of venom from the antPseudomyrmex, sp.In Handbook of Natural Toxins, Vol. 2, Insect Poisons, Aller-gens, and Other Invertebrate Venoms. A. T. Tu, editor. Marcel Dekker, New York. 243–290.
Philp, R. B. 1981. Methods of Testing Proposed Antithrombotic Drugs. CRC Press, Boca Raton, Florida. 278 pp.
Flower, R. J., S. Moncada, andJ. R. Vane. 1985. Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of gout.In The Pharmacological Basis of Therapeutics. A. G. Gilman, L. S. Goodman, T. S. Rall, and F. Murad, editors. Macmillan, New York. 674–715.
Detwiler, T. C., andE. M. Huang. 1986. Interactions of platelet activating pathways: Interrelationships of aggregation and secretion.In Platelet Responses and Metabolism, Vol. I. H. Holmsen, editor. CRC Press, Boca Raton, Florida. 235–249.
Mayo, J. R., S. S. Navran, Huzoor Akbar, D. D. Miller, andD. R. Feller. 1981. Stereo-dependent inhibition of human platelet function by the optical isomers of trimetoquinol.Biochem. Pharmacol. 30:2237–2241.
Born, G. V. R. 1962. Aggregation of blood platelets by adenosine diphosphate and its reversal.Nature 194:927–929.
Huzoor-Akbar, K. Romstedt, andB. Manhire. 1983. Computerized aggregation instruments: A highly efficient and versatile system for acquisition, quantitation, presentation and management of platelet aggregation data.Thromb. Res. 32:335–341.
Ahn, C.-H., A. Hamada, D. D. Miller, andD. R. Feller. 1986. Alpha-adrenoceptor mediated actions of optical isomers and desoxy analogs of catecholimidazoline and norepinephrine in human platelts in vitro.Biochem. Pharmacol. 35:4095–4102.
Hamberg, M., J. Svensson, T. Wakabayashi, andB. Samuelsson. 1974. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.Proc. Natl. Acad. Sci. U.S.A. 71:345–349.
Hamberg, M., J. Svensson, andB. Samuelsson. 1975. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides.Proc. Natl. Acad. Sci. U.S.A. 72:2994–2998.
Samuelsson, B. 1977. The role of prostaglandin endoperoxides and thromboxanes in human platelets.In Prostaglandins in Hematology, M. J. Silver, J. B. Smith and J. J. Kocsis, editors. Spectrum Publications, New York. 1–10.
Halushka, P. V., D. E. Mais, andD. L. Saussy, Jr. 1987. Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors.Fed. Proc. 46:149–153.
Coleman, R. A., I. Kennedy, G. P. Levy, andP. Lumley. 1981. Comparison of actions of U46619, a prostaglandin H2 analog, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.Br. J. Pharmacol. 73:773–778.
Bock, R. M., S. Ling, S. A. Morell, andS. H. Lipton. 1956. Ultraviolet absorption spectra of adenosine-5-triphosphate and related 5-ribonucleotides.Arch. Biochem. Biophys. 32:253–264.
Clayton, S., G. V. R. Born, andM. J. Cross. 1963. Inhibition of the aggregation of blood platelets by nucleosides.Nature 200:138–139.
Cross, M. J., G. V. R. Born, andS. Clayton. 1964. The aggregation of platelets by adenosine diphosphate.Thromb. Diath. Haemorrh. 11:301–302.
Born, G. V. R., R. J. Haslam, andM. Goldman. 1965. Comparative effectiveness of adenosine analogues as inhibitors of blood-platelet aggregation and as vasodilators in man.Nature 205:678–680.
Regoli, D., andV. Clark. 1963. Prevention by adenosine of the effect of adenosine diphosphate on the concentration of circulating platelets.Nature 200:546–548.
Haslam, R. J., andG. M. Rosson. 1975. Effects of adenosine on levels of adenosine cyclic 3,5-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.Mol. Pharmacol. 11:528–544.
Macfarlane, D. E.. 1987. Agonists and receptors: Adenosine diphosphate.In Platelet Responses and Metabolism, Vol. II. H. Holmsen, editor. CRC Press, Boca Raton, Florida. 19–36.
Bonne, C., B. Martic, andF. Regnault. 1980. The cyclic AMP-lowering effect of the stable endoperoxide analog U46619 in human platelets.Thromb. Res. 20:701–704.
Hirschhorn, R., F. Martiniuk, andF. S. Rosen. 1978. Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency.Clin. Immunol. Immunopathol. 9:287–292.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hink, W.F., Romstedt, K.J., Burke, J.W. et al. Inhibition of human platelet aggregation and secretion by ant venom and a compound isolated from venom. Inflammation 13, 175–184 (1989). https://doi.org/10.1007/BF00924788
Issue Date:
DOI: https://doi.org/10.1007/BF00924788